top of page
Filter posts by:
News
ICYMI: Rural Americans Need PBM Reform Now
Millions of rural Americans face a devastating health crisis. They suffer from high rates of chronic diseases yet face a severe shortage...
Mar 12
The 340B Drug Pricing Program: A Patient Benefit or PBM Profit Center?
Recent public financial disclosures from major health insurance conglomerates like CVS Health have shed light on a concerning trend: the...
Mar 7
House Energy and Commerce Subcommittee Members Highlight the Need for Urgent PBM Reforms
Last week, the House Energy and Commerce Committee’s Subcommittee on Health held a hearing entitled, “An Examination of How Reining in...
Mar 4
ICYMI: Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.
One employer was paying about $100 for a prescription for a generic antidepressant, though it could be bought elsewhere for about $12 A...
Jun 25, 2024
ICYMI: New York Times Investigation Shows PBMs Rip Off Just About Everyone
The New York Times has published a detailed investigation into how middlemen pharmacy benefit managers (PBMs) drive up drug costs for...
Jun 21, 2024
Watch: The role of PBMs, patents, and public health in drug pricing
This is Part 1 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. Watch here >
Jun 12, 2024
bottom of page